Trending...
- Spiritually Transformative Events Based on Bhagavad Gita – Path to a Fulfilling Life
- Author Deric Whaley's book 'The Ride' gives unique insider view on prison life
- Enable Accessible Haircare Wins Bronze at 2025 NACD Packaging Awards
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports.
TEMECULA, Calif. - illiNews -- Jellyfish Publication-Certified Nutraceuticals, Inc.
Gerald M. Haase, M.D.
Clinical Professor of Surgery, University of Colorado School of Medicine, Aurora, CO.
Neil E. Wolkodoff, PhD
Medical Program Director, Colorado Center for Health and Sports Science, Denver, CO.
May 16, 2025
Certified Nutraceuticals, Inc., a research and product development enterprise in Pauma Valley, California, U.S.A., announces the publication of an exciting new human clinical trial of its proprietary KollaJell™ collagen peptide formulation.
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports. The strength of this prospective, randomized trial is the distinctive utilization of a panel of brain function metrics from two robust, validated instruments, including a computerized neurocognitive test battery and an electroencephalographic (EEG) profile of voltage activation and wave phase pattern. Instead of evaluating only one or two parameters, this investigation assessed seven domains of cognitive function in 23 subjects who consumed KollaJell™ for a period of eight weeks.
More on illi News
The outcomes were clinically relevant, and all were statistically analyzed and achieved statistical significance. Standard scores matched for age and gender improved in all metrics regardless of the functional status of where the subject started. The parameters included compositive memory, neurocognitive index, visual memory, executive function and verbal memory. Under EEG monitoring conditions, the mean total reaction time and the trail-making composite test times also decreased dramatically. Topographic brain images showed voltage activation in the brain regions associated with sensory input and processing function. There were no adverse effects of consuming the supplement in any subject at any time during the study.
The importance of this pilot trial is the demonstration of a particularly extensive spectrum of beneficial results from the proprietary formulation compared to competing products that, even if helpful, provide only limited effects. In addition, the use of a marine-based natural collagen was superior to the usual animal-based products and the patented extraction process provided a greater platform of collagen types and a uniquely effective amino acid composition. This human clinical trial reinforces the concept that Certified Nutraceuticals KollaJell™ is a safe and beneficial collagen supplement that supports cognitive domains and memory and is applicable to a wide audience of potential consumers, regardless of their initial brain function status.
More on illi News
The actual medical study is available as a free open-access publication at https://www.auctoresonline.org/article/effects-of-a-jellyfish-collagen-based-amino-acid-supplement-on-cognitive-function-and-memory-a-pilot-investigation
For further information about the product or study, please contact:
Sara Alkayali at (951) 600-3899 or email: salkayali@certifiednutra.com
Gerald M. Haase, M.D.
Clinical Professor of Surgery, University of Colorado School of Medicine, Aurora, CO.
Neil E. Wolkodoff, PhD
Medical Program Director, Colorado Center for Health and Sports Science, Denver, CO.
May 16, 2025
Certified Nutraceuticals, Inc., a research and product development enterprise in Pauma Valley, California, U.S.A., announces the publication of an exciting new human clinical trial of its proprietary KollaJell™ collagen peptide formulation.
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports. The strength of this prospective, randomized trial is the distinctive utilization of a panel of brain function metrics from two robust, validated instruments, including a computerized neurocognitive test battery and an electroencephalographic (EEG) profile of voltage activation and wave phase pattern. Instead of evaluating only one or two parameters, this investigation assessed seven domains of cognitive function in 23 subjects who consumed KollaJell™ for a period of eight weeks.
More on illi News
- Tomorrow's World Today Shines Bright with Four Telly Awards at the 46th Annual Telly Awards
- AbbVie Partners with Chicago Cubs on "Striking Out Cancer"
- Chicago: Mayor Brandon Johnson, City Officials, Lamar Johnson Collaborative, and 548 Development Attend Groundbreaking of Mixed-Use West Humboldt Park Development
- ILLINOIS TEAMSTERS DEMAND LAWMAKERS PREVENT CATASTROPHIC CUTS TO PUBLIC TRANSPORTATION
- 6 Love Sports and Eight Sleep Announce Partnership Miami Women's Padel League Rebranded as the Eight Sleep Miami Women's Padel League by 6 Love Sports
The outcomes were clinically relevant, and all were statistically analyzed and achieved statistical significance. Standard scores matched for age and gender improved in all metrics regardless of the functional status of where the subject started. The parameters included compositive memory, neurocognitive index, visual memory, executive function and verbal memory. Under EEG monitoring conditions, the mean total reaction time and the trail-making composite test times also decreased dramatically. Topographic brain images showed voltage activation in the brain regions associated with sensory input and processing function. There were no adverse effects of consuming the supplement in any subject at any time during the study.
The importance of this pilot trial is the demonstration of a particularly extensive spectrum of beneficial results from the proprietary formulation compared to competing products that, even if helpful, provide only limited effects. In addition, the use of a marine-based natural collagen was superior to the usual animal-based products and the patented extraction process provided a greater platform of collagen types and a uniquely effective amino acid composition. This human clinical trial reinforces the concept that Certified Nutraceuticals KollaJell™ is a safe and beneficial collagen supplement that supports cognitive domains and memory and is applicable to a wide audience of potential consumers, regardless of their initial brain function status.
More on illi News
- The TOBU RAILWAY X COFFEE PROJECT Supports Nikko Tourism and Fosters English Speaking Guides, Through November 27, 2026
- Al-Tabbaa & Hackett: Fixed Rates Improve For Savers
- Zeigler Auto Group Earns its 12th Chicago's Best & Brightest Companies To Work For® Award
- Non-Citizen NY Travelers Face Extra Scrutiny at Local Airports: Attorney Robert Tsigler Featured in Gothamist
- $400 Million Run Rate in 2025 for Global Telcom Leader as a Result of Definitive Fintech Acquisition, Fast-Tracking $1 Billion Growth Plan: IQSTEL Inc
The actual medical study is available as a free open-access publication at https://www.auctoresonline.org/article/effects-of-a-jellyfish-collagen-based-amino-acid-supplement-on-cognitive-function-and-memory-a-pilot-investigation
For further information about the product or study, please contact:
Sara Alkayali at (951) 600-3899 or email: salkayali@certifiednutra.com
Source: Certified Nutraceuticals, Inc.
0 Comments
Latest on illi News
- Chicago: Mayor Johnson Announces $20 Million in Grant Awards for Community Development Projects
- $100 Million Financing Unlocked for Aggressive Acquisition and Growth Strategy Including Plan to Acquire Remote Lottery Platform: Stock Symbol: LTRY
- ARCH Dental + Aesthetics Unveils New Website for Enhanced Patient Experience
- GO2 Partners Named to PPAI 100 List
- Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies
- B&M Life Center Launches Urgent Fundraiser to Support Homeless and Impoverished in Greater Chicago
- The Future of Commerce Summit Returns to TECHICAGOWEEK 2025 with Innovation, AI and Entrepreneurship
- Chicago: ICYMI: Mayor Brandon Johnson Launches Summer Sports Series to Provide Safe Spaces During Holiday Weekends
- Juventix Regenerative Medical Announces Strategic Partnership with Juvasonic® to Expand Needle-Free Biologic Delivery Platform
- Agency EA Appoints Dee Hall to Board of Directors
- Discovering Cindy Crawford with Marie P. Anderson on The Isaiah Grass Show
- Prymax Media & Technology Group Acquires 'Hidden Treasures' From Estate of Jewel Records Founder Stan Lewis
- Mentor Agile Offers $0 Tuition Product Owner Training for WIOA-Approved Candidates in Chicago
- Midwest Pond Features Launches Seasonal Cleanout Services Across Chicagoland
- PHILLIPS LYTLE EXPANDS CHICAGO OFFICE TO FUEL MIDWEST GROWTH PLANS
- Cooking with the Godfather Blends Family Tradition, Italian Flavor, and Leadership Wisdom
- Group Seeks End to Mandated Community Psychiatric Programs, Citing Global Alarm
- CoreIntegrator Announces Sage Intacct Approved A/P One Integration, Becoming an Official Sage Partner
- New Romantic Comedy Professionally Unprofessional Turns Office Rivalry into Unforgettable Love
- H.P. Lovecraft Gets the Silent Treatment